At the news
? NEUTRALIMPACT 2/10 CLUSTER filed May 4, 2026 at 19:30 ET
A cluster of insider transactions at Edwards Lifesciences shows one open-market sale by a regional VP for $47K and a separate sale by a TAVR VP for $86K, alongside routine non-cash grants and tax-withholding events. The total open-market selling of $133K is negligible relative to the $46B market cap (0.0003%), making this a routine, non-material pattern.
- Total open-market sales: $133K (0.0003% of $46B market cap)
- Two selling insiders: CVP JAPAC (Markowitz) sold $47K; CVP TAVR (Lippis) sold $86K
- CEO Bernard Zovighian made only non-cash gifts and tax-withholding transactions, no open-market activity
- Multiple directors received stock grants (non-cash) on May 8, 2026, routine compensation
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access